EUVIMEDEUVIMED entdecken
Crossref

The cost of treating hypertension in Australia, 2012–22: an economic analysis

Emily R Atkins, Long Huy Nguyen, Mary Lou Chatterton, Markus Schlaich, Aletta E Schutte iD, Anthony Rodgers

Medical Journal of Australia · 2024

DOI: 10.5694/mja2.52522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Journal of Australia, 2024. Verfasst von Emily R Atkins und 5 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, Sydney, NSW. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To quantify the costs of hypertension diagnosis and treatment in Australia, particularly in primary care, including general practices and pharmacies. Study design Economic analysis; analysis of Pharmaceutical Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) data.

Setting

Australia, 2012–22. Main outcome measure Estimated expenditure on hypertension care (adjusted to 2022 Australian dollars), overall and by expenditure type (general practice consultations, medications), cost bearer (PBS, MBS, patient out‐of‐pocket costs), and broad expenditure category (medication costs, pharmacy costs, general practice consultations, ambulatory blood pressure monitoring).

Results

During 2012–22, estimated total expenditure for the diagnosis and treatment of hypertension in Australia was $12.2 billion: $7.3 billion (60%) was borne by the MBS and PBS, $4.9 billion (40%) by patients as out‐of‐pocket costs. During 2021–22, an estimated $1.2 billion was spent on the management of hypertension; the three main cost components were pharmacy‐related costs (administration and handling fees, dispensing fees, electronic prescription fees: $611.1 million, 50.8%), general practice consultations ($342.7 million, 28.5%), and blood pressure‐lowering medications (manufacturer and wholesale costs: $244.3 million, 20.3%).

Conclusions

During 2012–22, about 40% of the cost of managing hypertension in Australia was borne directly by patients (about $494 million per year). Important changes to pharmacy supply and payment policies were introduced in 2023, but further efforts may be needed to reduce treatment costs for patients. These changes are particularly important if the hypertension control rate is to be substantially improved in Australia, given the large numbers of undertreated and untreated people with hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAntihypertensive AgentsHumansAustraliaHealth ExpendituresPrimary Health CareGeneral PracticeDrug Costs

Stichwörter der Autor:innen

HypertensionPharmacoeconomicsPrimary care

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • The George Institute for Global Health, Sydney, NSW.
  • The University of New South Wales, Sydney, NSW.
  • Melbourne Medical School, the University of Melbourne, Melbourne, VIC.
  • Monash University, Melbourne, VIC.
  • Dobney Hypertension Centre, the University of Western Australia, Perth, WA.

ORCID-Profile: Aletta E Schutte

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Atkins, E. R., Nguyen, L. H., Chatterton, M. L., Schlaich, M., Schutte, A. E., & Rodgers, A. (2024). The cost of treating hypertension in Australia, 2012–22: an economic analysis. Medical Journal of Australia. https://doi.org/10.5694/mja2.52522

Vancouver

Atkins ER, Nguyen LH, Chatterton ML, Schlaich M, Schutte AE, Rodgers A. The cost of treating hypertension in Australia, 2012–22: an economic analysis. Medical Journal of Australia. 2024. doi:10.5694/mja2.52522

BibTeX
@article{Atkins2024,
  author = {Atkins, Emily R and Nguyen, Long Huy and Chatterton, Mary Lou and Schlaich, Markus and Schutte, Aletta E and Rodgers, Anthony},
  title = {The cost of treating hypertension in Australia, 2012–22: an economic analysis},
  journal = {Medical Journal of Australia},
  year = {2024},
  doi = {10.5694/mja2.52522}
}
Kostenlos starten →